Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells

被引:22
|
作者
Ko, Hyo Rim [1 ]
Chang, Yun Sil [2 ]
Park, Won Soon [2 ]
Ahn, Jee-Yin [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol,Ctr Mol Med, Suwon, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, 81 Irwonro, Seoul 06351, South Korea
关键词
Ebp1; oncogene; tumor suppressor gene; MEDIATED TRANSCRIPTION; LONG ISOFORM; EBP1; GROWTH; PHOSPHORYLATION; PROLIFERATION; EXPRESSION; REPRESSION; DIFFERENTIATION; IDENTIFICATION;
D O I
10.1002/ijc.30165
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The different functions of the two isoforms of ErbB3 binding protein 1 (Ebp1), p48 and p42, have recently become the focus of interest as they reveal contradictory roles in cell growth promoting ability. The conformational change that crystal structure of p42 was shown to lack a helices at the amino-terminus present in p48 represents the differential binding partners and protein modifications of two Ebp1 isoforms. N-terminal specific phosphorylation by CDK2 and deregulation of the p53 tumor suppressor through specific interaction with HDM2 and Akt activation is postulated to contribute to p48-mediated tumorigenesis. The short isoform p42 Ebp1, which is actual binding partner of ErbB3 has been implicated as a tumor suppressor with many binding partners such as Rb, HDAC2, Sin3A and the p85 subunit of PI3K with HSP70/CHIP, inhibiting its own antiproliferative activity or inhibiting PI3K activity. The aim of the current review is to provide a summary on distinctive cellular functions of two Ebp1 proteins and their molecular partners that might be responsible for the unique functions of each isoform of Ebp1.
引用
收藏
页码:1202 / 1208
页数:7
相关论文
共 50 条
  • [1] The roles of multifunctional protein ErbB3 binding protein 1 (EBP1) isoforms from development to disease
    Hwang, Inwoo
    Ko, Hyo Rim
    Ahn, Jee-Yin
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (07): : 1039 - 1047
  • [2] The roles of multifunctional protein ErbB3 binding protein 1 (EBP1) isoforms from development to disease
    Inwoo Hwang
    Hyo Rim Ko
    Jee-Yin Ahn
    Experimental & Molecular Medicine, 2020, 52 : 1039 - 1047
  • [3] Modulation of HCV replication and translation by ErbB3 binding protein1 isoforms
    Mishra, Priya
    Dixit, Updesh
    Pandey, Ashutosh K.
    Upadhyay, Alok
    Pandey, Virendra N.
    VIROLOGY, 2017, 500 : 35 - 49
  • [4] The role of ErbB3 binding protein 1 in cancer: Friend or foe?
    Dang Quan Nguyen
    Dinh Hoa Hoang
    Thanh Thao Nguyen Vo
    Vu Huynh
    Ghoda, Lucy
    Marcucci, Guido
    Le Xuan Truong Nguyen
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (12) : 9110 - 9120
  • [5] The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells
    Lu, Yan
    Zhou, Hua
    Chen, Wantao
    Zhang, Yuexing
    Hamburger, Anne W.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (01) : 27 - 36
  • [6] The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells
    Yan Lu
    Hua Zhou
    Wantao Chen
    Yuexing Zhang
    Anne W. Hamburger
    Breast Cancer Research and Treatment, 2011, 126 : 27 - 36
  • [7] Functional roles of the erbB3 receptor in human keratinocytes
    Farrington, D. L.
    Lewis, D. A.
    Spandau, D. F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 70 - 70
  • [8] Regulation of the ErbB3 binding protein Ebp1 by protein kinase C
    Lessor, TJ
    Hamburger, AW
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 175 (1-2) : 185 - 191
  • [9] Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells
    D Akinmade
    A H Talukder
    Y Zhang
    W-m Luo
    R Kumar
    A W Hamburger
    British Journal of Cancer, 2008, 98 : 1132 - 1140
  • [10] Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells
    Akinmade, D.
    Talukder, A. H.
    Zhang, Y.
    Luo, W-m
    Kumar, R.
    Hamburger, A. W.
    BRITISH JOURNAL OF CANCER, 2008, 98 (06) : 1132 - 1140